allaboutbleeding.com is an informative resource for the von Willebrand disease community brought to you by CSL Behring, a CSL Company. As a company with a long combined history of creating a stable supply of life-saving therapies, CSL Behring (formerly ZLB Behring), provides plasma-derived and recombinant products that are used in the treatment of individuals with von Willebrand disease, hemophilia, and immune deficiency disorders as well as the treatment of cardiac surgery patients and burn victims. For more information about CSL Behring, please visit CSLBehring.com.

CSL Behring’s Marketing, Medical Affairs, Regulatory, Legal, and IS departments are responsible for the content and development of allaboutbleeding.com. CSL Behring would like to acknowledge the Canadian Hemophilia Society for granting permission to use portions of their booklet, "All About von Willebrand Disease," in developing this web site. We would also like to acknowledge our team of experts, Jamie Siegel, MD and Julie Hambleton, MD, for their contributions to allaboutbleeding.com.

The information provided on allaboutbleeding.com is designed to support, not replace, the relationship that exists between you and your physician.

Informational content shows the date content was first published and the date the content was last updated.

allaboutbleeding.com does not host or receive funding from advertising.

For more information or if you have any questions, please contact the Webmaster at Webmaster@allaboutbleeding.com